Kalmar Investments Inc. DE cut its stake in shares of Equifax Inc. (NYSE:EFX) by 26.6% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 226,530 shares of the company’s stock after selling 82,220 shares during the period. Equifax comprises approximately 1.3% of Kalmar Investments Inc. DE’s investment portfolio, making the stock its 24th largest position. Kalmar Investments Inc. DE owned approximately 0.19% of Equifax worth $29,086,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. American Century Companies Inc. bought a new stake in shares of Equifax during the second quarter valued at $90,891,000. Credit Agricole S A increased its stake in shares of Equifax by 485.3% in the first quarter. Credit Agricole S A now owns 420,030 shares of the company’s stock valued at $48,005,000 after buying an additional 348,262 shares during the period. Samlyn Capital LLC bought a new stake in shares of Equifax during the first quarter valued at $33,099,000. Standard Life Investments LTD increased its stake in shares of Equifax by 23.6% in the second quarter. Standard Life Investments LTD now owns 1,032,294 shares of the company’s stock valued at $132,532,000 after buying an additional 196,930 shares during the period. Finally, Nuveen Asset Management LLC increased its stake in shares of Equifax by 1,121.0% in the first quarter. Nuveen Asset Management LLC now owns 174,364 shares of the company’s stock valued at $19,928,000 after buying an additional 160,083 shares during the period. Hedge funds and other institutional investors own 88.62% of the company’s stock.

Institutional Ownership by Quarter for Equifax (NYSE:EFX)

Shares of Equifax Inc. (NYSE:EFX) traded up 0.58% during mid-day trading on Tuesday, hitting $130.28. The company had a trading volume of 382,625 shares. Equifax Inc. has a 52-week low of $91.72 and a 52-week high of $136.97. The stock has a market cap of $15.55 billion, a price-to-earnings ratio of 33.92 and a beta of 0.87. The stock’s 50-day moving average is $132.32 and its 200-day moving average is $127.18.

Equifax (NYSE:EFX) last released its quarterly earnings data on Wednesday, July 27th. The company reported $1.43 EPS for the quarter, beating the consensus estimate of $1.36 by $0.07. Equifax had a return on equity of 24.51% and a net margin of 16.11%. The company had revenue of $811.30 million for the quarter, compared to analyst estimates of $802.85 million. During the same period last year, the company posted $1.15 earnings per share. The firm’s revenue was up 19.6% compared to the same quarter last year. Equities analysts forecast that Equifax Inc. will post $5.38 earnings per share for the current year.

EFX has been the topic of several recent research reports. Barclays PLC upped their price target on Equifax from $140.00 to $150.00 and gave the stock an “overweight” rating in a report on Wednesday, September 21st. Zacks Investment Research upgraded Equifax from a “hold” rating to a “buy” rating and set a $147.00 price target on the stock in a report on Tuesday, September 27th. Deutsche Bank AG upped their price target on Equifax from $125.00 to $145.00 and gave the stock a “buy” rating in a report on Friday, July 29th. JPMorgan Chase & Co. upped their price objective on Equifax from $133.00 to $155.00 and gave the stock an “overweight” rating in a research report on Friday, July 29th. Finally, Jefferies Group reaffirmed a “hold” rating and set a $128.00 price objective on shares of Equifax in a research report on Thursday, July 28th. Two equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus target price of $140.11.

In other Equifax news, Chairman Richard F. Smith sold 48,432 shares of the firm’s stock in a transaction dated Wednesday, August 17th. The stock was sold at an average price of $130.51, for a total value of $6,320,860.32. Following the transaction, the chairman now directly owns 253,228 shares of the company’s stock, valued at $33,048,786.28. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider J Dann Adams sold 4,422 shares of the firm’s stock in a transaction dated Friday, July 29th. The shares were sold at an average price of $134.00, for a total value of $592,548.00. Following the completion of the transaction, the insider now directly owns 57,804 shares in the company, valued at $7,745,736. The disclosure for this sale can be found here. 2.01% of the stock is owned by company insiders.

Equifax Company Profile

Equifax Inc is a provider of information solutions and human resources business process outsourcing services for businesses, governments and consumers. The Company operates through four segments: U.S. Information Solutions (USIS), International, Workforce Solutions and Personal Solutions. USIS provides consumer and commercial information solutions to businesses in the United States, including online information, decisioning technology solutions, fraud and identity management services, portfolio management services, mortgage reporting and financial marketing services.

5 Day Chart for NYSE:EFX

Receive News & Stock Ratings for Equifax Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Equifax Inc. and related stocks with our FREE daily email newsletter.